Although our CCL2 inhibition and transfer experiments suggested that LN Vγ6+ γδ T cells capable of producing IL-17 were recruited to joints (where they induced arthritis) via CCR2–CCL2 interaction, development of arthritis was not completely suppressed by treatment with anti-CCL2 mAb. This evidence concerns the gene CCR2 and arthritic joint disease.